You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Moodys
Express Scripts
Mallinckrodt
Johnson and Johnson

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PF-06305591

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PF-06305591?

PF-06305591 is an investigational drug.

There have been 4 clinical trials for PF-06305591. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2013.

The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There is one US patent protecting this investigational drug and nine international patents.

Recent Clinical Trials for PF-06305591
TitleSponsorPhase
Cold Pressor Test is Used in This Study to Assess the Effect of PF-06305591 on Pain Intensity Evoked by Cold in Healthy Male SubjectsPfizerPhase 1
Safety and Tolerability Study of Multiple Doses of PF-06305591PfizerPhase 1
Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic FlarePfizerPhase 1

See all PF-06305591 clinical trials

Clinical Trial Summary for PF-06305591

Top disease conditions for PF-06305591
Top clinical trial sponsors for PF-06305591

See all PF-06305591 clinical trials

International Patents for PF-06305591

Drugname Country Document Number Estimated Expiration Related US Patent
PF-06305591 Argentina 089865 2032-02-03   Start Trial
PF-06305591 Canada 2861439 2032-02-03   Start Trial
PF-06305591 European Patent Office 2809655 2032-02-03   Start Trial
PF-06305591 Spain 2548228 2032-02-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Moodys
Express Scripts
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.